Castle Biosciences, Inc. (CSTL)
USD 26.52
(-5.76%)
USD 26.52
(-5.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -135 Thousand | -41.65 Million | -18.98 Million | 9.86 Million | 7.01 Million | -12.29 Million |
| Net Income | -57.46 Million | -67.13 Million | -31.29 Million | -10.28 Million | 5.27 Million | -6.36 Million |
| Depreciation & Amortization | 12.33 Million | 10.54 Million | 3.4 Million | 472 Thousand | 358 Thousand | 323.01 Thousand |
| Deferred income taxes | -223 Thousand | -1.87 Million | -8.73 Million | 1.39 Million | -2.28 Million | 272.41 Thousand |
| Stock-based compensation | 51.21 Million | 36.32 Million | 21.74 Million | 8.3 Million | 1.24 Million | 293.63 Thousand |
| Change in working capital | -6.63 Million | -7000.00 | -4.1 Million | 9.14 Million | 44 Thousand | -7.35 Million |
| Other non-cash items | 635 Thousand | -19.49 Million | 33.04 Million | 823 Thousand | 2.36 Million | 542.37 Thousand |
| Investing Cash Flow | -16.18 Million | -166.54 Million | -66.65 Million | -4.74 Million | -937 Thousand | -277.03 Thousand |
| Investments in PPE | -13.62 Million | -5.63 Million | -3.48 Million | -4.75 Million | -937 Thousand | -277.03 Thousand |
| Acquisitions | 13 Thousand | -26.96 Million | -63.18 Million | 3000.00 | - | - |
| Investment purchases | -189.07 Million | -134.68 Million | - | - | - | - |
| Sales/Maturities of investments | 186.5 Million | - | - | - | - | - |
| Other Investing Activities | -2.56 Million | 742 Thousand | 10 Thousand | 3000.00 | - | - |
| Financing Cash Flow | -2.29 Million | 1.51 Million | 5.42 Million | 305.89 Million | 88.28 Million | 15.83 Million |
| Debt repayment | -142 Thousand | -122 Thousand | -8000.00 | -27.35 Million | -15 Thousand | -5.41 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.13 Million | -1.68 Million | -781 Thousand | - | - | - |
| Common Stock Issuance | 269 Thousand | 833 Thousand | 3.89 Million | 330.04 Million | 67.15 Million | 10.42 Million |
| Other Financing Activities | -2.42 Million | 4.18 Million | 5.42 Million | 3.2 Million | 88.3 Million | 15.83 Million |
| Accounts receivables | -14.93 Million | -6.21 Million | -4.63 Million | 1.66 Million | -896 Thousand | -8.4 Million |
| Accounts payables | 5.7 Million | 582 Thousand | -182 Thousand | 169 Thousand | 557 Thousand | 197.24 Thousand |
| Inventory | -3.96 Million | -1.68 Million | 327 Thousand | -980 Thousand | -355 Thousand | -577.65 Thousand |
| Other working capital | 6.55 Million | 7.3 Million | 384 Thousand | 8.29 Million | 738 Thousand | 1.42 Million |
| Cash at beginning of period | 122.94 Million | 329.63 Million | 409.85 Million | 98.84 Million | 4.47 Million | 1.21 Million |
| Cash at end of period | 98.84 Million | 122.94 Million | 329.63 Million | 409.85 Million | 98.84 Million | 4.47 Million |
| Capital Expenditure | -13.62 Million | -5.63 Million | -3.48 Million | -4.75 Million | -937 Thousand | -277.03 Thousand |
| Effect of forex changes on cash | -5.49 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -24.1 Million | -206.68 Million | -80.21 Million | 311 Million | 94.36 Million | 3.26 Million |
| Free Cash Flow | -13.75 Million | -47.28 Million | -22.46 Million | 5.11 Million | 6.07 Million | -12.57 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.26 Million | 8.92 Million | -2.53 Million | -2.58 Million | -57.46 Million | -6.9 Million |
| Depreciation & Amortization | 3.54 Million | 3.34 Million | 3.34 Million | 3.22 Million | 12.33 Million | 3.17 Million |
| Deferred income taxes | 5.25 Million | -1.54 Million | - | -236 Thousand | -223 Thousand | 32 Thousand |
| Stock-based compensation | 13.02 Million | 13.17 Million | 12.67 Million | 11.8 Million | 51.21 Million | 13.04 Million |
| Change in working capital | 16.88 Million | 1.91 Million | -18.79 Million | 7.66 Million | -6.63 Million | -2.8 Million |
| Other non-cash items | -17.63 Million | 23.01 Million | 22.22 Million | 4.2 Million | 635 Thousand | -1.53 Million |
| Investing Cash Flow | -14.78 Million | -21.41 Million | -19.7 Million | -7.67 Million | -16.18 Million | -9.7 Million |
| Investments in PPE | -6.37 Million | -5.22 Million | -9.15 Million | -3.79 Million | -13.62 Million | -2.45 Million |
| Acquisitions | -7000.00 | 2000.00 | 5000.00 | 3000.00 | 13 Thousand | 2000.00 |
| Investment purchases | -45.21 Million | -52.44 Million | -60.75 Million | -52.38 Million | -189.07 Million | -50.25 Million |
| Sales/Maturities of investments | 36.8 Million | 36.25 Million | 50.2 Million | 48.5 Million | 186.5 Million | 43 Million |
| Other Investing Activities | 11 Thousand | -16.18 Million | -10.54 Million | -3.87 Million | -2.56 Million | -7.25 Million |
| Financing Cash Flow | 838 Thousand | 42 Thousand | 10.64 Million | -3.29 Million | -2.29 Million | 45 Thousand |
| Debt repayment | -9.9 Million | -11 Thousand | -9.96 Million | -142 Thousand | -142 Thousand | -36 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 1.08 Million | -615 Thousand | -474 Thousand | -4.01 Million | -5.13 Million | -271 Thousand |
| Common Stock Issuance | -73 Thousand | 8000.00 | 65 Thousand | 72 Thousand | 269 Thousand | 13 Thousand |
| Other Financing Activities | 9.72 Million | 34 Thousand | 10.57 Million | -3.22 Million | -2.42 Million | 597 Thousand |
| Accounts receivables | -4.25 Million | -3.35 Million | -4.26 Million | -1.15 Million | -14.93 Million | -5.8 Million |
| Accounts payables | -2.15 Million | -1.22 Million | -422 Thousand | 3.01 Million | 5.7 Million | -378 Thousand |
| Inventory | 1.44 Million | -368 Thousand | 297 Thousand | -2.17 Million | -3.96 Million | 352 Thousand |
| Other working capital | 7.54 Million | 6.86 Million | -14.4 Million | 7.97 Million | 6.55 Million | 3.02 Million |
| Cash at beginning of period | 85.57 Million | 82.94 Million | 98.84 Million | 91.22 Million | 122.94 Million | 95.87 Million |
| Cash at end of period | 94.95 Million | 85.57 Million | 82.94 Million | 98.84 Million | 98.84 Million | 91.22 Million |
| Capital Expenditure | -6.37 Million | -5.22 Million | -9.15 Million | -3.79 Million | -13.62 Million | -2.45 Million |
| Effect of forex changes on cash | - | - | - | -624 Thousand | -5.49 Million | 13.99 Million |
| Net cash flow / Change in cash | 9.38 Million | 2.62 Million | -15.89 Million | 7.61 Million | -24.1 Million | -4.65 Million |
| Free Cash Flow | 16.96 Million | 18.76 Million | -15.98 Million | 20.28 Million | -13.75 Million | 2.55 Million |
AREC
BALY
TPZ
QIIK
SADHNANIQ
QC7